Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib ResistanceTapan K. Maity, Udayan Guha|Cancers|2023Cited by 9